Gastrointestinal market to reach $44B valuation by 2028

The global GI market is expected to reach a $43,712.47 million valuation by 2028, growing at a rate of 3.33 percent according to a July report from Market Growth Reports

In 2021, the market was estimated at a $34,748.18 million valuation. 

There are several key players in the global GI market who are expected to continue dominating the market going forward, including AstraZeneca, Pfizer, Teva and Abbot.

The GI market includes medications and services used for treatment of illnesses including Crohn's, IBS and colitis. 

The report also covers growth in the market across North America, Europe, Asia-Pacific, South America, and the Middle East and Africa. 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Whitepapers

Featured Podcast